The 2027 WADA World Anti-Doping Code: analysis of the main novelties

On January 1, 2027, the new World Anti-Doping Code of the World Anti-Doping Agency (WADA) will enter into force, together with the updated International Standards, intended to replace the currently applicable regulatory framework. The reform is the result of an extensive international review and consultation process,which unfolded over approximately two years and culminated in the approval of the new Code by the WADA Foundation Board and of the Standards by the Executive Committee, on the occasion of the Sixth World Conference on Doping in Sport, held in Busan, Republic of Korea, on December 5, 2025. The final versions in English and French were subsequently published by WADA. The text and official documentation are available in the section dedicated to the 2027 World Anti-Doping Code.
If you are an athlete, a coach, a sports physician, or another professional involved in anti-doping proceedings,or if you wish to verify the implications of the new Code on your activity, you can contact us for a legal assessment of your position.
This intervention forms part of the periodic review of the international anti-doping regulatory system, which previously led to the adoption of earlier versions of the Code in 2004, 2009, 2015, and 2021. The 2027 revision amends numerous substantive and procedural provisions, pursuing a more nuanced balance between the effectiveness of doping prevention and enforcement activities, the individualization of sanctioning consequences, the protection of fundamental rights, and procedural fairness.
The overarching theme of the reform is the pursuit of greater proportionality in the response to anti-doping rule violations, accompanied by a strengthening of procedural safeguards and oversight mechanismsover the activities of Anti-Doping Organizations. This evolution does not entail the abandonment of the fundamental principles of the system, nor does it bring about a general relaxation of sanctions. Strict liability of the athlete for the presence of a prohibited substance in their biological sample remains one of the cornerstones of the anti-doping legal order; what changes, above all, is the ability to differentiate more precisely the consequences of the violation based on the established circumstances, the conduct of the person concerned, and the available scientific evidence.
One of the most significant amendments concerns the sanctioning system set forth in Article 10.2.1 of the Code, with reference to violations involving the presence or use of prohibited substances or methods not classified as Specified Substances or Specified Methods. The framework retains, as a general rule, the four-year period of ineligibility, but introduces a more structured framework for cases in which the conduct is not intentional or the context of ingestion presents specific characteristics. In particular, where the athlete is able to establish both how the substance entered their body and that the violation was not intentional, the period of ineligibility may be reduced to two years, without prejudice to the further application of provisions allowing for the elimination or reduction of consequences in the cases provided for by the Code. The reform also introduces an intermediate regime for cases where the athlete fails to establish that the violation was not intentional, but establishes how the substance entered their body and demonstrates that the context of its ingestion was unrelated to sport performance enhancement. In this situation, the applicable period of ineligibility is three years.
The new system also contemplates an exceptional scenario: where the athlete fails to establish the source of the substance, the sanction may nevertheless be reduced to two years if reliable scientific evidence demonstrates that the violation is incompatible with an intentional use of the prohibited substance. This is, however, a circumscribed option, intended to operate in specific situations and characterized by a particularly stringent burden of proof. The same provision expressly excludes the reliability of polygraph tests as evidence in anti-doping proceedings.
The main innovation therefore lies in establishing a system that attaches greater weight to proof of the origin of the substance, the context of its ingestion, and the compatibility of the established circumstances with intentional conduct. The practical scope of these provisions will depend on the athlete's ability to reconstruct in a documented manner the routes of exposure to the substance and on the availability of scientific evidence suitable to support their position. The new Code does not eliminate the burdens of proofresting on the person concerned and does not introduce a general presumption that a violation was unintentional.
A second area of intervention concerns the so-called Substances of Abuse, a category comprising substances frequently abused in society outside the context of sport, for which the anti-doping system has progressively recognized the need for an approach more attentive to the health and personal dimension of the athlete. The new Article 10.2.3 introduces specifications that differentiate the treatment of the violation depending on the timing of ingestion, its connection to sport performance, and any prior violations.
For a first violation involving the out-of-competition use of a Substance of Abuse, where it is established that the ingestion was unrelated to sport performance, a two-month period of ineligibility is provided. In the event of a second violation, the standard period is four months, with the possibility of a reduction to two months where the athlete satisfactorily completes an appropriate substance abuse treatment program, or where the Anti-Doping Organization determines that such a program is not necessary under the specific circumstances. Conversely, if the ingestion occurs in-competition, but it is established that it was unrelated to sport performance, the period of ineligibility may range from six months to two years, depending on the circumstances of the case.
The reform also eliminates mandatory provisional suspensions for violations involving Substances of Abuse that do not fall within the category of Specified Substances. This amendment reflects an approach aimed at drawing a clearer distinction between conduct genuinely aimed at enhancing sport performance and situations characterized by personal or health-related issues. The decisive factor remains the reconstruction of the circumstances of ingestion and their actual relationship to sporting activity.
Particularly significant, especially in the management of proceedings based on the presence of prohibited substances, is the expansion of the rules governing sources of contamination. The 2027 Code replaces the previous reference to Contaminated Products with a broader concept of Contaminated Source. This amendment allows consideration of a wider variety of situations in which inadvertent exposure to a prohibited substance may stem not only from contaminated supplements or products, but also from food, beverages, environmental exposures, accidental contact, or other circumstances capable of causing the presence of the substance in the body.
The significance of this change must be assessed in light of the evidentiary difficulties that frequently characterize anti-doping proceedings. Proving contamination may require complex scientific analyses, testing of the composition of products used, reconstructions of the athlete's dietary habits and clinical history, as well as an analysis of possible routes of exposure. Recognizing a broader category of contamination sources allows the sanctioning assessment to be aligned more closely with the actual facts of the case, rather than limiting it to scenarios traditionally associated solely with supplements or commercial products.
Contamination does not, however, automatically exclude anti-doping liability. Its relevance must be evaluated in relation to the available evidence, the origin of the substance, the athlete's conduct, and the requirements laid down by the Code for the elimination or reduction of consequences. In practice, the new rules expand the scope for an individualized assessment, but do not exempt the athlete from the need to provide a credible evidentiary reconstruction.
Another novelty concerns authorizations for therapeutic purposes, known as Therapeutic Use Exemptions (TUEs). The new Article 10.2.4 provides a specific sanctioning regime for cases in which the athlete establishes that the use of the prohibited substance or method would have met the criteria set out in the International Standard for Therapeutic Use Exemptions at the time of ingestion, with the exception of the requirement regarding the absence of a reasonable permitted therapeutic alternative. Where these conditions are met, the period of ineligibility is fixed at two months and cannot be further reduced through the mechanisms indicated in the provision.
This intervention seeks to regulate more predictably situations in which the use of a prohibited substance addresses genuine medical needs, but the athlete failed to obtain the required authorization in advance.However, the rule does not equate to an automatic retroactive grant of a TUE: a distinction must be drawn between the procedure aimed at obtaining recognition of a therapeutic exemption and the assessment of the disciplinary consequences of any violation. The existence of the medical and regulatory prerequisites must be demonstrated through adequate medical documentation compliant with the criteria established by the applicable International Standard.
TUE management is also affected by amendments aimed at improving coordination among Anti-Doping Organizations. In particular, exemptions granted by National Anti-Doping Organizations will, as a general rule, be automatically recognized by other national organizations, International Federations, and Major Event Organizations, subject to specific derogations authorized by WADA.
The 2027 Code also modifies the conditions for obtaining a sanction reduction through cooperation with Anti-Doping Organizations. The Substantial Assistance regime is made more flexible, removing the requirement that the assistance must necessarily lead to a formal proceeding, sanction, or other formal outcome against the person involved. Instead, what becomes decisive is the capacity of the information provided to enable the Anti-Doping Organization to discover facts constituting an anti-doping rule violation.
Alongside this mechanism, an additional possibility for reduction is introduced—up to 15% of the otherwise applicable period of ineligibility—for individuals who provide information of significant value in the fight against doping, even if it falls short of the threshold required to qualify as Substantial Assistance. This measure is designed to recognize the investigative contribution of the person concerned even in situations where the information does not directly identify another perpetrator or result in a sanctioning decision against third parties.
A further incentive for the early resolution of proceedings concerns the admission of the violation and the acceptance of the consequences proposed by the Anti-Doping Organization. The new Article 10.8.1expands the mechanism already provided under the 2021 Code. Where the period of ineligibility asserted in the notice of charge is less than four years, the athlete may obtain a 25% reduction, provided they admit the violation and accept all asserted consequences within twenty days of receiving the formal notice. For sanctions of four years or more, the one-year reduction mechanism remains available in the cases contemplated by the provision, whereas the benefit does not apply to lifetime periods of ineligibility under this specific rule.
On an institutional level, the reform introduces strengthened oversight mechanisms regarding the activities of Anti-Doping Organizations. Among the most notable innovations is the establishment of the Independent Review Expert, provided for in Article 7.8 of the new Code. Under specific circumstances, when an Anti-Doping Organization intends to depart from the standard results management process after receiving notice of an Adverse Analytical Finding—including deciding not to proceed with standard disciplinary action—it will be required to obtain the prior written opinion of the independent expert. This opinion does not replace the decision-making authority of the Anti-Doping Organization, but introduces an additional verification step aimed at promoting consistency, transparency, and accountability in results management. Failure to comply with this procedure may trigger compliance consequences for the organization under the Code, should it subsequently emerge on appeal that the violation ought to have been pursued.
Governance strengthening also extends to the operational independence of National Anti-Doping Organizations and hearing panels. The new Code further clarifies the requirement of independence for National Anti-Doping Organizations in their operational decisions and activities, with particular emphasis on autonomy from sport bodies and governmental authorities. Additionally, a new International Standard for Intelligence and Investigations is introduced, aimed at structuring the collection and evaluation of information more systematically and ensuring that investigative activities are grounded in reasonable,objective, and proportionate grounds.
The 2027 Code also reforms the appeals system by introducing a harmonized standard deadline of twenty-one days to file an appeal, in accordance with the procedures set out in Article 13.2.3.4. Under the scenarios governed by the rule, the deadline runs from the relevant date of receipt of the decision or, where the complete case file has been timely requested, from the subsequent receipt of the complete file. The rules contain specific provisions governing WADA's standing and the various categories of parties entitled to appeal.Furthermore, the reform expands the range of appealable decisions and clarifies the appeal rights granted to additional interested parties. Expressly included among appealable decisions, in the cases specified, are decisions not to bring forward proceedings following certain Athlete Biological Passport results, failures to impose or decisions to lift a provisional suspension, whereabouts failures, and decisions regarding retroactive Therapeutic Use Exemption applications.
Specific attention is devoted to the protection of Minors and Protected Persons. The new Code expands the safeguards applicable during testing, investigations, and hearings, recognizing the specific needs associated with the athlete's age and personal circumstances. In certain situations, a parent or representative may participate in the sample collection process via video link when physical presence is not possible; similar assistance arrangements may be utilized for athletes with visual or intellectual impairments where necessary.
The framework also intensifies scrutiny of the conduct of Athlete Support Personnel, including coaches,trainers, physicians, and other professionals. Enhanced procedural safeguards and stricter scrutiny of the responsibilities of adults working with minors are established, including specific investigative duties in cases identified by the Code. Restrictions are also introduced regarding the mandatory public disclosure of certain information relating to anti-doping rule violations committed by Minors, Recreational Athletes, and Protected Persons.
Amendments concerning the protection of personal data align with this same perspective. The new framework clarifies the conditions for using samples and data for scientific research purposes, strengthening anonymization requirements and identifying circumstances in which athlete consent or authorization from the competent body is required. It also specifies the conditions for the public reporting of anti-doping decisions, distinguishing between situations where disclosure is mandatory and those requiring the consent of the person concerned, subject to specific exceptions.
The system of athlete Whereabouts obligations is likewise subject to clarifications and operational amendments. The Code further clarifies the criteria for assessing fault in whereabouts failures and establishes more precise rules for determining which Anti-Doping Organization has results management authority,particularly when multiple bodies hold testing jurisdiction over the same athlete. Amendments to the International Standards also introduce operational guidance on submitting travel and training location information, with particular focus on athletes included in Registered Testing Pools. For athletes competing in team sports, the implementing provisions also set out specific rules regarding the submission of team training schedules and collective travel itineraries where applicable. Consequently, compliance with the new regime cannot be assessed solely on the basis of knowledge of prohibited substances: proper management of reporting obligations, testing windows, and communications with Anti-Doping Organizations remains essential to avoid procedural violations.
In this regard, it is appropriate to distinguish the World Anti-Doping Code from the Prohibited List. These are distinct instruments, albeit integrated within the same international system. The Code governs violations,liability, consequences, and procedural safeguards; the List, by contrast, identifies substances and methods prohibited at all times, those prohibited in-competition, and those prohibited only in particular sports. The 2027 WADA Prohibited List was approved on September 10, 2026, and will likewise enter into force on January 1, 2027. Among the reported changes are clarifications concerning Substances of Abuse and cannabinoids,terminological updates, and certain clarifications regarding substance classes and affected sports.
Finally, the transition to the new regime requires an assessment of the provisions applicable ratione temporis.Indeed, the entry into force of the 2027 Code does not mean that all of its substantive provisions are automatically applicable retroactively to any prior violation. Transitional provisions must be examined in relation to the date of the alleged conduct, the stage of the proceedings, and the specific provisions of the Code, also taking into account the principle of lex mitior where applicable. For pending proceedings or matters relating to events prior to January 1, 2027, determining the applicable rules must be carried out on a case-by-case basis, without presuming either the full application of the new regime or the irrelevance of its more favorable provisions.
Overall, the new World Anti-Doping Code represents a significant evolution of the international system, aimed at making the assessment of violations more nuanced, the determination of sanctions more coherent, and anti-doping proceedings better safeguarded. Greater flexibility in considering contamination, the rules on Substances of Abuse, the treatment of certain cases connected to Therapeutic Use Exemptions, incentives for cooperation and early case resolution, as well as new oversight mechanisms and fundamental rights guarantees, all contribute to shaping a regulatory framework more responsive to the specifics of individual cases.
The system continues to require strict compliance with anti-doping obligations and attaches decisive weight to proof of the circumstances in which the violation occurred. Where applicable, the new avenues for sanction reduction presuppose concrete evidentiary elements and an accurate reconstruction of the facts.At the same time, the strengthening of procedural safeguards makes the proper management of the notification, analysis, charge, and appeal phases even more critical.
Dr. Mario Piroli
© ALL RIGHTS RESERVED – the use of the contents is authorized provided that the author and the website are cited as the source.
WADA World Anti-Doping Code, World Anti-Doping Code, World Anti-Doping Code Italian, WADA Code PDF, WADA Code summary, WADA Italy, WADA List, what WADA does, WADA prohibited substances,2027 WADA Code, WADA TUE, anti-doping sports regulations, anti-doping sports code, NADO Italia, 2027 WADA List, updated anti-doping regulations, NADO Italia 2027, anti-doping lawyer, anti-doping law firm



